A story in U.K. newspaper The Mirror concerns the higher risk of “third-generation” contraceptive pills, compared to ones that have been on the market for longer.
It concerns two different studies by the Boston University School of Medicine into two different types of birth control. The results were published in the British Medical Journal.
The studies concluded that “the difference in threat was dramatic” between older oral contraceptives containing levonorgestrel and relatively ...
continue reading...
Switzerland’s largest health insurer announced that it’s supporting a young woman who has filed suit against pharmaceutical giant Bayer, claiming the company’s Yasmin birth control pill caused a pulmonary embolism that left her severely disabled.
The U.S. Food and Drug Administration has approved Skyla, an intrauterine device manufactured by Bayer.
